| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
PESI
Perma-Fix
|
Aug 13, 2026 | BUY |
Strong Buy
+67.0% avg upside
1 analyst
|
$30.00
66.96% Upside
|
+0.0% | · |
|
ARQ
Arq Inc
|
Aug 12, 2026 | BUY |
Strong Buy
+700.6% avg upside
10 analysts
|
$3.50
53.43% Upside
|
-0.9% | · |
|
SHIM
Shimmick Corporation
|
Aug 11, 2026 | BUY |
Strong Buy
+87.6% avg upside
2 analysts
|
$7.00
87.60% Upside
|
-7.9% | · |
|
BWMN
Bowman Consulting Group
|
Aug 11, 2026 | HOLD |
Buy
+6.6% avg upside
11 analysts
|
$43.00
1.96% Upside
|
-0.1% | · |
|
CECO
Ceco Environmental
|
Aug 11, 2026 | BUY |
Strong Buy
+25.0% avg upside
13 analysts
|
$118.00
53.64% Upside
|
+2.5% | · |
|
QRHC
Quest Resource
|
Aug 07, 2026 | BUY |
Strong Buy
+408.6% avg upside
6 analysts
|
$2.50
71.15% Upside
|
+6.7% | · |
|
NPKI
NPK International
|
Jul 31, 2026 | BUY |
Strong Buy
+82.0% avg upside
12 analysts
|
$22.00
58.85% Upside
|
+12.2% | · |
|
ORN
Orion Group Holdings
|
Jul 30, 2026 | BUY |
Strong Buy
+22.7% avg upside
15 analysts
|
$15.00
54.97% Upside
|
+3.8% | · |
|
BW
Babcock & Wilcox Company
|
Jul 13, 2026 | BUY |
Buy
+30.5% avg upside
7 analysts
|
— | -5.9% | · |
|
DAKT
Daktronics
|
Jun 25, 2026 | BUY |
Buy
+1.0% avg upside
4 analysts
|
$32.00
56.52% Upside
|
+9.3% | · |
|
LYTS
Lsi Industries
|
Jun 22, 2026 | BUY |
Strong Buy
-3.3% avg upside
7 analysts
|
— | -5.9% | · |
|
CERT
Certara
|
Apr 22, 2026 | HOLD |
Buy
+61.3% avg upside
22 analysts
|
— | +25.4% | · |
|
TPB
Turning Point Brands
|
Apr 21, 2026 | BUY |
Strong Buy
+6.1% avg upside
10 analysts
|
$140.00
62.14% Upside
|
+23.8% | · |
|
MGNI
Magnite
|
Mar 24, 2026 | BUY |
Strong Buy
+2.3% avg upside
28 analysts
|
— | +105.6% | · |
|
GPRE
Green Plains
|
Mar 10, 2026 | BUY |
Buy
+7.2% avg upside
14 analysts
|
— | +2.4% | · |
|
ADTN
Adtran
|
Jan 22, 2026 | BUY |
Buy
+76.5% avg upside
11 analysts
|
— | -22.9% | · |
|
HCKT
The Hackett Group
|
Dec 02, 2025 | BUY |
Strong Buy
+47.9% avg upside
4 analysts
|
— | -41.8% | · |
|
BHST
BioHarvest Sciences
|
Nov 11, 2025 | BUY |
Strong Buy
+328.9% avg upside
5 analysts
|
— | -62.8% | · |
|
TSEM
Tower
|
Nov 07, 2025 | BUY |
Strong Buy
-10.6% avg upside
10 analysts
|
— | +215.8% | · |
|
AMRC
Ameresco
|
Oct 29, 2025 | BUY |
Strong Buy
+44.8% avg upside
20 analysts
|
— | -29.5% | · |
|
GENI
Genius Sports Limited
|
Sep 03, 2025 | BUY |
Strong Buy
+32.3% avg upside
26 analysts
|
— | -35.8% | · |
|
TRNS
Transcat
|
Aug 25, 2025 | BUY |
Strong Buy
-4.7% avg upside
9 analysts
|
$111.00
17.05% Upside
|
-0.4% | · |
|
JYNT
Joint
|
Jun 25, 2025 | HOLD |
Buy
+31.3% avg upside
9 analysts
|
$10.50
24.67% Upside
|
-19.9% | · |
|
EVLV
Evolv Technologies Holdings
|
Jun 25, 2025 | BUY |
Strong Buy
+59.8% avg upside
9 analysts
|
— | -14.1% | · |
|
PCT
PureCycle Technologies
|
Jun 18, 2025 | HOLD |
Buy
+74.8% avg upside
10 analysts
|
$13.00
85.76% Upside
|
-36.4% | · |
|
OKLO
Oklo Inc
|
Mar 05, 2025 | BUY |
Strong Buy
+103.3% avg upside
25 analysts
|
— | +104.8% | · |
|
INOD
Innodata
|
Nov 01, 2024 | BUY |
Strong Buy
+97.8% avg upside
8 analysts
|
— | +253.1% | · |
|
FENC
Fennec Pharmaceuticals
|
Oct 28, 2024 | BUY |
Strong Buy
+36.0% avg upside
9 analysts
|
— | +85.2% | · |
|
EHTH
Ehealth
|
Sep 04, 2024 | BUY |
Hold
+1206.8% avg upside
19 analysts
|
— | +3.7% | · |
|
TSE:ELVA
Electrovaya
|
Jul 11, 2024 | BUY |
Strong Buy
+68.3% avg upside
11 analysts
|
— | +52.0% | · |
|
LFMD
LifeMD
|
Apr 16, 2024 | BUY |
Strong Buy
+199.2% avg upside
14 analysts
|
— | -49.3% | · |
|
PSIX
Power Solutions
|
Mar 18, 2024 | BUY |
Strong Buy
+7.7% avg upside
9 analysts
|
$8.00
80.54% Downside
|
+1357.3% | · |
|
AMSC
American Superconductor
|
Feb 12, 2024 | BUY |
Strong Buy
+28.2% avg upside
15 analysts
|
— | +132.9% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.